GLRA
Gerald L. Ray & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $25M | Sell |
55,899
-281
| -0.5% | -$126K | 3.12% | 3 |
|
|
2017
Q2 | $27.6M | Sell |
56,180
-175
| -0.3% | -$85.9K | 3.56% | 3 |
|
|
2017
Q1 | $21.8M | Sell |
56,355
-943
| -2% | -$365K | 2.99% | 4 |
|
|
2016
Q4 | $21M | Sell |
57,298
-786
| -1% | -$289K | 3.05% | 3 |
|
|
2016
Q3 | $23.4M | Sell |
58,084
-139
| -0.2% | -$55.9K | 3.5% | 3 |
|
|
2016
Q2 | $20.3M | Sell |
58,223
-750
| -1% | -$262K | 3.25% | 3 |
|
|
2016
Q1 | $21.3M | Sell |
58,973
-2,730
| -4% | -$984K | 3.44% | 3 |
|
|
2015
Q4 | $33.5M | Sell |
61,703
-873
| -1% | -$474K | 5.29% | 2 |
|
|
2015
Q3 | $29.1M | Sell |
62,576
-1,140
| -2% | -$530K | 4.85% | 2 |
|
|
2015
Q2 | $32.5M | Sell |
63,716
-1,160
| -2% | -$592K | 4.95% | 1 |
|
|
2015
Q1 | $29.3M | Sell |
64,876
-1,255
| -2% | -$567K | 4.41% | 3 |
|
|
2014
Q4 | $27.1M | Sell |
66,131
-304
| -0.5% | -$125K | 4.17% | 3 |
|
|
2014
Q3 | $24M | Sell |
66,435
-775
| -1% | -$279K | 3.9% | 3 |
|
|
2014
Q2 | $19M | Sell |
67,210
-660
| -1% | -$186K | 3.24% | 3 |
|
|
2014
Q1 | $20.4M | Sell |
67,870
-515
| -0.8% | -$155K | 3.69% | 2 |
|
|
2013
Q4 | $18.8M | Sell |
68,385
-1,255
| -2% | -$345K | 3.55% | 2 |
|
|
2013
Q3 | $21.8M | Sell |
69,640
-850
| -1% | -$266K | 4.51% | 1 |
|
|
2013
Q2 | $15.9M | Buy |
+70,490
| New | +$15.9M | 3.55% | 1 |
|